These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36389774)

  • 1. Phage therapy for
    Fujimoto K; Uematsu S
    Front Immunol; 2022; 13():1057892. PubMed ID: 36389774
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta-analysis.
    Pomares Bascuñana RÁ; Veses V; Sheth CC
    Lett Appl Microbiol; 2021 Aug; 73(2):149-158. PubMed ID: 33864273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of the gut microbiome following fecal microbiota transplantation.
    Seekatz AM; Aas J; Gessert CE; Rubin TA; Saman DM; Bakken JS; Young VB
    mBio; 2014 Jun; 5(3):e00893-14. PubMed ID: 24939885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
    Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
    mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridioides difficile phage biology and application.
    Heuler J; Fortier LC; Sun X
    FEMS Microbiol Rev; 2021 Sep; 45(5):. PubMed ID: 33580957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor.
    Whittle MJ; Bilverstone TW; van Esveld RJ; Lücke AC; Lister MM; Kuehne SA; Minton NP
    Microbiol Spectr; 2022 Feb; 10(1):e0229521. PubMed ID: 35107319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
    Cappetto CM
    Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fecal microbiota transplantation in an older patient with Clostridioides difficile recurrent infection. Report of one case].
    Núñez P; Quera R; Von Muhlenbrock C; Concha A; Flores K
    Rev Med Chil; 2022 Oct; 150(10):1396-1400. PubMed ID: 37358099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Fecal Microbiota Transplantation in Recurrent
    Parnell JM; Nicholson MR; Kellermayer R; Kahn SA
    Pediatr Ann; 2021 Dec; 50(12):e515-e521. PubMed ID: 34889135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of
    Miguel A
    Br J Nurs; 2023 Jun; 32(12):546-549. PubMed ID: 37344135
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
    Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
    Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological mechanisms of fecal microbiota transplantation in recurrent
    Soveral LF; Korczaguin GG; Schmidt PS; Nunes IS; Fernandes C; Zárate-Bladés CR
    World J Gastroenterol; 2022 Sep; 28(33):4762-4772. PubMed ID: 36156924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy.
    Mehta SR; Yen EF
    Transl Res; 2021 Apr; 230():197-207. PubMed ID: 33278650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal microbiota transplantation for
    Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
    United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in IgA-targeted microbiota following fecal transplantation for recurrent
    Huus KE; Frankowski M; Pučić-Baković M; Vučković F; Lauc G; Mullish BH; Marchesi JR; Monaghan TM; Kao D; Finlay BB
    Gut Microbes; 2021; 13(1):1-12. PubMed ID: 33382360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.
    Chauhan A; Apostolov R; van Langenberg D; Garg M
    Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
    Tan X; Johnson S
    Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
    Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.